Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.

Angiogenesis is in part related to mast cells. However, the biological significance of mast cells within lung carcinoma remains unclear. Immunohistochemistry was used to stain for tryptase, CD34 and vascular endothelial growth factor (VEGF) in 85 cases of stage I nonsmall cell lung carcinoma. VEGF was found in 33 of 53 adenocarcinomas and 14 of 32 squamous cell carcinomas. Cases of adenocarcinoma had significantly higher mast cell counts than those of squamous cell carcinoma. In adenocarcinoma, mast cell counts in VEGF-positive tumours were significantly higher than in VEGF-negative tumours, whereas in squamous cell carcinoma they were not. Good correlation was observed between intratumoural mast cell counts and microvessel counts. Double staining showed most intratumoural mast cells expressed VEGF. Importantly, only in lung adenocarcinoma, members in the high mast cell count group had significantly worse prognosis than those in the low mast cell count group. It is concluded that tumour-released vascular endothelial growth factors may be related to mast cell accumulation, intratumoural mast cells may produce vascular endothelial growth factor, and stromal mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.

[1]  S. Abe,et al.  Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. , 1999, American journal of respiratory and critical care medicine.

[2]  T. Yamaguchi,et al.  Clara cell protein-positive epithelial cells are reduced in small airways of asthmatics. , 1999, American journal of respiratory and critical care medicine.

[3]  P. Wolters,et al.  Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. , 1999, Journal of immunology.

[4]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  H. Dvorak,et al.  Mast Cells Can Secrete Vascular Permeability Factor/ Vascular Endothelial Cell Growth Factor and Exhibit Enhanced Release after Immunoglobulin E–dependent Upregulation of Fcε Receptor I Expression , 1998, The Journal of experimental medicine.

[6]  D. Yee,et al.  Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. , 1998, Cancer Research.

[7]  R K Jain,et al.  Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. , 1998, The Journal of investigative dermatology.

[8]  S. Abe,et al.  Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  P. Welker,et al.  Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. , 1998, Molecular biology of the cell.

[10]  J. Miller,et al.  Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. , 1998, The Journal of thoracic and cardiovascular surgery.

[11]  L. A. Richards,et al.  Increased mast cell density in invasive melanoma , 1998, Journal of cutaneous pathology.

[12]  K. Nishioka,et al.  Expression of stem cell factor in basal cell carcinoma , 1997, The British journal of dermatology.

[13]  A. Naukkarinen,et al.  Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions , 1997, International journal of cancer.

[14]  S. Ren,et al.  Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. , 1997, The Journal of clinical investigation.

[15]  C. Angeletti,et al.  Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. , 1997, British Journal of Cancer.

[16]  M. Koutsilieris,et al.  Mast cell-tumor cell interactions: for or against tumour growth and metastasis? , 1997, Anticancer research.

[17]  Yung‐Chie Lee,et al.  Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. , 1995, American journal of respiratory and critical care medicine.

[18]  R. Kew,et al.  Angiogenic factors stimulate mast-cell migration. , 1995, Blood.

[19]  J. Lachter,et al.  Mast cells in colorectal neoplasias and premalignant disorders , 1995, Diseases of the colon and rectum.

[20]  S. Kondo,et al.  Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. , 1993, Biochemical and biophysical research communications.

[21]  K. Donhuijsen,et al.  Mast cell frequency in soft tissue tumors. Relation to type and grade of malignancy. , 1992, Pathology, research and practice.

[22]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[23]  K. Suzuki,et al.  Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. , 1989, The Journal of clinical investigation.

[24]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[25]  J. Starkey,et al.  Mast‐cell‐deficient W/Wv mice exhibit A decreased rate of tumor angiogenesis , 1988, International journal of cancer.

[26]  K. Barrett,et al.  Mast cell numbers and histamine levels in synovial fluids from patients with diverse arthritides. , 1986, Arthritis and rheumatism.

[27]  H. Maartmann-Moe,et al.  Mast cell changes and tumour dissemination in human breast carcinoma. , 1984, Invasion & metastasis.

[28]  Ľ.,et al.  Angiogenic Factors Stimulate Mast-Cell Migration , 2022 .